1 P: 1800 098 809 E: [email protected] W: painchek.com PainChek Limited (ASX: PCK) | PG 1 ABN 21 146 035 127 Suite 401, 35 Lime Street, Sydney, NSW, 2000, Australia ASX ANNOUNCEMENT 29 July 2026 30 June 2026 Quarterly Activities Report and Appendix 4C ...
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from PainChek
- PainChek receives $1.123 million R&D tax incentive refund
- US MedTech leader Karen Holzberger appointed CEO
- CEO Transition
- PainChek secures A$5.5m note to fund US expansion
- Landmark Sabra North America deployment targeting 20k beds
Later from PainChek
- Change of Director's Interest Notice x 4
- Update - Notification regarding unquoted securities - PCK
- PainChek Investor Webinar
- Appendix 4E and Financial Report
- Resignation of Non-Executive Director
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek